Steer clear of these leaders & laggards

Article Excerpt

Here are some of the best- and worst-performing North American ETFs of the past year. But regardless of their return, we don’t recommend any of these funds. The Leaders: iPath Global Carbon ETN $21 (OTC symbol GRNTF; Market cap: $10.6 million) provides exposure to the global carbon-credits market. These credits are traded on the open market and let companies emit specified levels of carbon from factories and power stations. These investments carry a high level of risk given the price volatility of carbon credits. For example, on the last trading day in May 2018, this ETF’s share price dropped 15%. It’s still up 57% over the last 3 months, but could give back those gains, too. Sell. Invesco DWA Momentum Healthcare ETF $89 (Nasdaq symbol PTH; Market cap: $207.6 million) invests in publicly listed U.S. health-care companies. Its 62.7% return over the past year beat the 12.3% gain for the more broadly defined Dow Jones US Healthcare Index. However, the ETF focuses on momentum…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.